Carol R. Lizak - Sep 13, 2021 Form 4 Insider Report for Jaguar Health, Inc. (JAGX)

Role: Chief Financial Officer
Signature: /s/ Carol R. Lizak
Stock symbol: JAGX
Transactions as of: Sep 13, 2021
Transactions value $: $20,000
Form type: 4
Date filed: 3/30/2022, 09:32 PM
Next filing: Apr 6, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	JAGX	Common Stock	Purchase	$20K	+7.97K		$2.51	7.97K	Sep 13, 2021	See Footnote	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	JAGX	Restricted stock units	Award	$0	+97K		$0.00	97K	Mar 28, 2022	Common Stock	97K		Direct	F2, F3, F4, F5

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Securities held directly by the Peter & Carol Lizak Revocable Trust. Ms. Lizak, by virtue of her position as a co-trustee and beneficiary of such trust and her sharing of voting and investment control over the securities held by the trust with her spouse, may be deemed to beneficially own the securities held by the Peter & Carol Lizak Trust for purposes of Section 16.
F2	Granted pursuant to the issuer's 2014 Stock Incentive Plan.
F3	Each restricted stock unit represents a contingent right to receive one share of the issuer's common stock.
F4	The restricted stock unit grants were approved by the issuer's board of directors on March 28, 2022.
F5	The restricted stock units vest in three equal annual installments beginning on May 17, 2023. Vested shares will be delivered to the reporting person on the vesting date provided in the grant notice.